Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ulcer 1Tomaculous neuropathy 1Thrombocythemia, Essential 1Stomatitis 1Stomach Neoplasms 1Radiation Pneumonitis 1Primary Myelofibrosis 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Neuroma 1Myeloproliferative Disorders 1Median Neuropathy 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hand Injuries 1Disease 1Carpal Tunnel Syndrome 1Breast Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 2Low-Level Light Therapy 2Cisplatin 2Xylitol 1Standard of Care 1Specimen Handling 1Radiotherapy, Image-Guided 1RRx-001 1Practice Guidelines as Topic 1Platinum 1Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin 1Magnetic Resonance Spectroscopy 1Injections 1Granulocyte-Macrophage Colony-Stimulating Factor 1Folic Acid 1Betaine 1Acetylcysteine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Stomatitis × Acetylcysteine × Clear all
NCT06354712 2025-01-15

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

Mansoura University

Phase 2 Recruiting
50 enrolled

Stomatitis, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡